Publication | Open Access
FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
216
Citations
32
References
2016
Year
This study provides Class III evidence that elevated S-FGF21 accurately distinguishes patients with mitochondrial myopathies from patients with other conditions, and FGF21 and GDF15 mitochondrial myopathy from other myopathies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1